Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 8 Lung Neoplasms 4 Small Cell Lung Carcinoma 2 Neoplasms 2 Thoracic Neoplasms 1 SCLC 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma 1 Ovarian Neoplasms 1 Non Small Cell Lung Cancer NSCLC 1 Neoplasms by Site 1 Lung Diseases 1 Extensive Stage Small Cell Lung Cancer 1 Endometrial Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Bronchogenic 1 Bronchial Neoplasms 1 Adenocarcinoma 1

Interventions

durvalumab 2 tremelimumab 1 ceralasertib 1 aflutinib 1 Radiotherapy 1 Pemetrexed 1 Gemcitabine 1 Cisplatin 1 Carboplatin 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Non Small Cell Lung Cancer NSCLC × ceralasertib × Thoracic × Clear all

NCT06680050 2025-12-18

AUSTRAL

Mario Negri Institute for Pharmacological Research

Phase 2 Recruiting

Non Small Cell Lung Cancer NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡